Specialized Healthcare & Pharmaceutical Legal Advisory
We provide legal architecture for healthcare and pharma deals, focusing on complex M&A, cross-border acquisitions, and private equity investments.
We advised the Infinx group on a significant primary equity investment by global investment firm KKR. This deal showcases our capability in structuring and executing major private equity transactions in the technology and healthcare sectors, helping innovative companies accelerate their growth.
We advised MedGenome, a leading genomic diagnostics company, on its Series E fundraise of approximately USD 47.5 million. This transaction supports the company's mission to broaden access to affordable, genetics-based diagnostics across emerging markets.
We advised health-tech startup Zeno Health on its $25 million Series C funding round led by STIC Investments. This transaction demonstrates our ability to guide growth-stage companies in securing capital for market expansion and technological enhancement.
We advised Infinx on its strategic acquisition of i3 Verticals' Healthcare Revenue Cycle Management (RCM) business for approximately USD 96 million. This deal expanded our client's footprint in the US healthcare market, particularly with academic medical centers.
Our team advised Infinx on its acquisition of Glidian, Inc. through a reverse triangular merger. This complex, cross-border transaction strengthened our client's patient access solutions and expanded their presence in the laboratory and healthcare technology market.
We advised Infinx on the acquisition of the assets and operations of Medreceivables Advisor, LLC (MRA). This deal strengthened our client's capabilities in specialized pathology coding and billing, expanding their service offerings in the US healthcare revenue cycle management space.
We guided Zeno Health, a health-tech pharmacy platform, on its acquisition of Tablt Pharmacy's assets on a slump sale basis. This transaction was structured to expand Zeno Health's last-mile medicine supply services into underserved markets across Eastern India.
We advised Ind-Swift Laboratories and its promoters on the INR 1,650 crore sale of its API and CRAMS businesses to IndiaRF. The complex deal involved advising on the business sale and a subsequent investment by our client into the acquiring entity.
About Specialized Sector Advisory: Healthcare & Pharma
In the healthcare sector, regulatory hurdles are as significant as the financial terms. Whether we are structuring an asset slump sale or a reverse triangular merger, our focus is on ensuring that the business continuity remains intact while navigating the strict regulatory frameworks of the drug and medical device industries. We do not just draft documents; we architect the transaction to withstand scrutiny from both regulators and your board.
Navigating Complex M&A
Healthcare transactions, such as the USD 96 million acquisition of i3 Verticals' RCM business by Infinx, require more than standard legal drafting. We manage the intricacies of cross-border deals, including reverse triangular mergers and asset transfers. Our work involves a deep dive into the regulatory landscape, ensuring that intellectual property, patient data compliance, and operational permits are seamlessly transitioned.
Private Equity & Funding Rounds
We support health-tech startups through critical capital infusion stages. Our involvement in transactions like MedGenome’s USD 47.5 million Series E fundraise and Zeno Health’s USD 25 million Series C round demonstrates our expertise in managing investor expectations, conducting due diligence, and structuring agreements that allow for future growth while protecting the founders' vision.
Regulatory & Strategic Execution
For established players like Ind-Swift Laboratories, we advise on large-scale divestments and CRAMS business sales. This requires a comprehensive understanding of sectoral regulations, from competition analysis to tax-efficient deal structuring. We assist in identifying red flags early, providing risk quantification that informs your commercial assessment. Our firm bridges the gap between complex legal statutes and the practical realities of the Indian healthcare market, ensuring that your corporate goals are met with precise, legally sound strategy.
Krishnava Dutt
My team and I take a methodical approach to the healthcare and pharma sector. We understand that in this industry, the legal framework must be as precise as the science behind your business. We are here to guide you through high-stakes acquisitions, Series-stage funding, and the regulatory complexities that define this space.
Looking for specialized legal support in another sector?
You can refine your search by specific practice areas or industry expertise.
More from Corporate, M&A & Private Equity by Krishnava Dutt